Chas P. Smith & Associates (CPS)’s Novo Nordisk NVO Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.6M	Buy	950,151 +148,565	+19%	+$6.38M	2.31%	18
2026 Q1	$29.5M	Buy	801,586 +230,875	+40%	+$10.9M	1.6%	29
2025 Q4	$29M	Buy	570,711 +165,286	+41%	+$8.45M	1.53%	28
2025 Q3	$22.5M	Buy	405,425 +207,959	+105%	+$12.2M	1.95%	20
2025 Q2	$13.6M	Buy	197,466 +116,413	+144%	+$7.92M	0.77%	37
2025 Q1	$5.63M	Buy	+81,053	New	+$6.69M	0.33%	43

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Chas P. Smith & Associates (CPS)'s NVO Position: Q2 2026 in Review

Chas P. Smith & Associates (CPS) increased its Novo Nordisk (NVO) stake by 19% in Q2 2026, buying an estimated $6.38M and bringing the position to 950,151 shares worth $45.6M. The position accounts for 2.31% of the portfolio, ranked #18.

Chas P. Smith & Associates (CPS) first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Chas P. Smith & Associates (CPS) held 950,151 shares of Novo Nordisk worth $45.6M as of Q2 2026.
Chas P. Smith & Associates (CPS) bought 148,565 Novo Nordisk shares in Q2 2026, an estimated $6.38M.
Novo Nordisk made up 2.31% of Chas P. Smith & Associates (CPS)'s portfolio in Q2 2026, its #18 holding.
Chas P. Smith & Associates (CPS) first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q2 2026, filed 11 Sep 2026.